JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB326438

Anti-Sialoadhesin/CD169 antibody [EPR30523-549]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal Sialoadhesin/CD169 antibody. Suitable for Flow Cyt, ICC/IF and reacts with Human samples.

View Alternative Names

CD169, SN, SIGLEC1, Sialoadhesin, Sialic acid-binding Ig-like lectin 1, Siglec-1

3 Images
Flow Cytometry - Anti-Sialoadhesin/CD169 antibody [EPR30523-549] (AB326438)
  • Flow Cyt

Lab

Flow Cytometry - Anti-Sialoadhesin/CD169 antibody [EPR30523-549] (AB326438)

Flow cytometric analysis of Human PBMC isolated CD14+ monocytes treated with IFNa (1000 IU/ml ) for 24 hours (Lower left and right) Human PBMC (human peripheral blood mononuclear cell) isolated CD14+ monocytes (Upper left and right) cells labelling Sialoadhesin/CD169 with ab326438 at 1/50 dilution (1ug) / Upper right and Lower right compared with a Rabbit monoclonal IgG (ab172730) / Left isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody).

Goat anti-Rabbit IgG (Alexa Fluor® 647, ab150083) at 1/5000 dilution was used as the secondary antibody.

Gated on viable cells. Cells were co-stained with anti-CD14 conjugated to Brilliant Violet 421.

Immunocytochemistry/ Immunofluorescence - Anti-Sialoadhesin/CD169 antibody [EPR30523-549] (AB326438)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-Sialoadhesin/CD169 antibody [EPR30523-549] (AB326438)

Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized Human PBMC (human peripheral blood mononuclear cell) isolated CD14+ monocytes Human PBMC isolated CD14+ monocytes treated with IFNa (1000 IU/ml ) for 24 hours Human CD14 depleted PMBC Human CD14 depleted PMBC treated with IFNa (1000 IU/ml ) for 24 hours cells labelling Sialoadhesin/CD169 with ab326438 at 1/50 (10.1 µg/ml) dilution , followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 dilution (Green).

Confocal image showing membranous and cytoplasmic staining in Human PBMC isolated CD14+ monocytes treated with IFNa (1000 IU/ml ) for 24 hours(shown in green). The counterstain was observed in magenta. Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8). A : Human PBMC (human peripheral blood mononuclear cell) isolated CD14+ monocytes B : Human PBMC isolated CD14+ monocytes treated with IFNa (1000 IU/ml ) for 24 hours C : Human CD14 depleted PMBC D : Human CD14 depleted PMBC treated with IFNa (1000 IU/ml ) for 24 hours

ab7291 Anti-alpha Tubulin mouse monoclonal antibody was used to counterstain tubulin at 1/1000 dilution (Magenta). The Nuclear counterstain was DAPI (Blue).

Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 dilution.

Flow Cytometry - Anti-Sialoadhesin/CD169 antibody [EPR30523-549] (AB326438)
  • Flow Cyt

Lab

Flow Cytometry - Anti-Sialoadhesin/CD169 antibody [EPR30523-549] (AB326438)

Flow cytometric analysis of Human CD14 depleted PMBC treated with IFNa (1000 IU/ml ) for 24 hours (Lower left and right) Human CD14 depleted PMBC (Upper left and right) cells labelling Sialoadhesin/CD169 with ab326438 at 1/50 dilution (1ug) / Upper right and Lower right compared with a Rabbit monoclonal IgG (ab172730) / Left isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody).

Goat anti-Rabbit IgG (Alexa Fluor® 647, ab150083) at 1/5000 dilution was used as the secondary antibody.

Gated on viable cells. Cells were co-stained with anti-CD3 conjugated to Brilliant Violet 421.

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR30523-549

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, Flow Cyt

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/50", "FlowCyt-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50", "ICCIF-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Macrophage-restricted adhesion molecule that mediates sialic-acid dependent binding to lymphocytes, including granulocytes, monocytes, natural killer cells, B-cells and CD8 T-cells. Plays a crucial role in limiting bacterial dissemination by engaging sialylated bacteria to promote effective phagocytosis and antigen presentation for the adaptive immune response (PubMed : 12940982, PubMed : 33489013). Mediates the uptake of various enveloped viruses via sialic acid recognition and subsequently induces the formation of intracellular compartments filled with virions (VCCs) (PubMed : 28129379). In turn, enhances macrophage-to-T-cell transmission of several viruses including HIV-1 or SARS-CoV-2 (PubMed : 28129379, PubMed : 34782760). Acts as an endocytic receptor mediating clathrin dependent endocytosis. Preferentially binds to alpha-2,3-linked sialic acid (PubMed : 12940982). Binds to SPN/CD43 on T-cells (By similarity). May play a role in hemopoiesis. Plays a role in the inhibition of antiviral innate immune by promoting TBK1 degradation via TYROBP and TRIM27-mediated ubiquitination (PubMed : 26358190).. (Microbial infection) Facilitates viral cytoplasmic entry into activated dendritic cells via recognition of sialylated gangliosides pesent on viral membrane.
See full target information SIGLEC1

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com